Lupin Limited has informed the Exchange about update on acquisition of minority shareholding in Multicare Pharmaceuticals Philippines, Inc.
LUPIN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Lupin's wholly owned subsidiary Nanomi B.V. is acquiring minority shareholding in Multicare Pharmaceuticals Philippines, Inc., which is already a subsidiary of Nanomi. The transaction, originally expected to close by end of May 2026, has been delayed and is now expected to complete in July 2026. The deal remains subject to certain closing conditions. This is a routine status update on an ongoing acquisition with no new material terms disclosed.
The delay of approximately one month is not material for shareholders. The transaction is proceeding normally and completion is expected shortly, with no change to the strategic rationale of the acquisition.